The plummeting cost of genome sequencing may likely spur a jump in healthcare spending, Forbes contributor Peter Ubel says, and he thinks that maybe something ought to be done about that.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genomic analysis of 200 bird species, and more.
The Australian High Court rules that isolated genetic material cannot be patented.
The startup incubator Y Combinator is launching a nonprofit research lab.
Tomas Lindahl, Paul Modrich, and Aziz Sancar share this year's Nobel Prize in Chemistry for their studies of DNA repair mechanisms.